Technical Analysis for SBIO - ALPS Medical Breakthroughs ETF
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Inside Day | Range Contraction | 0.75% | |
| Gapped Up | Strength | 0.75% | |
| Overbought Stochastic | Strength | 1.47% | |
| Down 3 Days in a Row | Weakness | 1.47% | |
| 50 DMA Resistance | Bearish | -0.92% | |
| NR7 | Range Contraction | -0.92% | |
| Narrow Range Bar | Range Contraction | -0.92% |
| Alert | Time |
|---|---|
| Up 1% | about 7 hours ago |
| 60 Minute Opening Range Breakout | 1 day ago |
| Rose Above 10 DMA | 1 day ago |
| Up 1% | 1 day ago |
| Gap Up Partially Closed | 1 day ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM.
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.
Keywords: Exchange Traded Fund ETF Index Fund Biotechnology Pharmaceutical Passive Management
Classification
Keywords: Exchange Traded Fund ETF Index Fund Biotechnology Pharmaceutical Passive Management
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 38.8 |
| 52 Week Low | 23.1558 |
| Average Volume | 11,315 |
| 200-Day Moving Average | 30.81 |
| 50-Day Moving Average | 34.22 |
| 20-Day Moving Average | 33.12 |
| 10-Day Moving Average | 34.13 |
| Average True Range | 0.68 |
| RSI (14) | 52.38 |
| ADX | 17.5 |
| +DI | 26.47 |
| -DI | 28.98 |
| Chandelier Exit (Long, 3 ATRs) | 32.87 |
| Chandelier Exit (Short, 3 ATRs) | 33.03 |
| Upper Bollinger Bands | 35.31 |
| Lower Bollinger Band | 30.93 |
| Percent B (%b) | 0.69 |
| BandWidth | 13.22 |
| MACD Line | 0.08 |
| MACD Signal Line | -0.07 |
| MACD Histogram | 0.1486 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 34.41 | ||||
| Resistance 3 (R3) | 34.40 | 34.23 | 34.33 | ||
| Resistance 2 (R2) | 34.23 | 34.12 | 34.24 | 34.31 | |
| Resistance 1 (R1) | 34.09 | 34.04 | 34.01 | 34.10 | 34.28 |
| Pivot Point | 33.93 | 33.93 | 33.88 | 33.93 | 33.93 |
| Support 1 (S1) | 33.78 | 33.81 | 33.70 | 33.79 | 33.61 |
| Support 2 (S2) | 33.62 | 33.73 | 33.62 | 33.59 | |
| Support 3 (S3) | 33.47 | 33.62 | 33.56 | ||
| Support 4 (S4) | 33.48 |
